PLoS paper says Zoloft literature ghostwritten

A paper that ran in PLoS said between 18% and 40% of the medical literature on sertaline (Zoloft) that was published in medical journals between 1998 and 2000 was ghostwritten or managed by a single medical education company acting on behalf of the manufacturer.
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.